Omega-3 compound shows promise in lab study to fight inflammation
NCT ID NCT05161702
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether a special form of omega-3 (monoglycerides) can help reduce inflammation in blood cells. Researchers will take blood from 200 healthy adults, treat the cells in a lab dish with an inflammatory agent, and then add the omega-3 compound to see if it lowers inflammation. The goal is to understand how omega-3s might work to resolve inflammation at the cellular level.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- omega-3 monoglycerides (MAG-SPM)
- What this could lead to
- If successful, this could point toward a new way to treat inflammation using omega-3s.
- What could go wrong
- This is a very early lab study using cells in a dish, not in people. It may not translate to real-world benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REDUCTION OF CELL PROLIFERATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
SCF Pharma
RECRUITINGRimouski, Quebec, G0K 1P0, Canada